Trecento: in silico network-driven identification of target combinations for combination therapy

In recent years, there has been a gradual paradigm shift in the drug industry towards combination therapyafter the “one-target one-drug” (mono-therapy) approach fails to increase the number of successful drugs. Although, the use of multiple drugs in a therapy is potentially useful for addressing diseases ( .g., cancer) that implicate multiple genes and pathways, there is also a higher possibility of drug toxicity that is caused by various factors including the compounding ofoff-target effectsof individual drugs. Careful selection of target combination is an important step towards reducing attrition rate of new drug combinations during preclinical and clinical phases. Although various techniques have been suggested for target selection, they generally apply to mono-therapies. Many of these approaches ( e.g., affinity matrix) cannot be applied directly to target combination identification because they lack consideration of interaction between targets that affects efficacy and toxicity profiles of drug combinations hitting these targets. In addition, the few proposed approach for target combination identification all suffer from certain key limitations. First, they assume that all targets are equally probable for a combination. However, targets influence effects of the combinations differently and appropriate choice of targets can potentially improve the target combinations. Second, they demand specific technical expertise from users ( e.g., knowledge of what off-target effects to optimize) and a lack of the required expertise can undermine the effectiveness of the method. In this dissertation, we seek to address these limitations by proposing a framework called TRECENTO(In SilicoNeTwork-dRiven IdEntifiCation of TargEt CombiNaTions for COmbination Therapy). TRECENTO uses a network-based approach for identifying target combinations in xix ATTENTION: The Singapore Copyright Act applies to the use of this document. Nanyang Technological University Library

[1]  Read OnlineThe,et al.  The Biology of Cancer , 2022, Nature.

[2]  Hans-Georg Müller,et al.  Functional Data Analysis , 2016 .

[3]  S. Zohar,et al.  Competing designs for drug combination in phase I dose‐finding clinical trials , 2015, Statistics in medicine.

[4]  Sourav S. Bhowmick,et al.  One feature doesn't fit all: characterizing topological features of targets in signaling networks , 2014, BCB.

[5]  Michael J. MacDonald,et al.  Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase , 2014, Nature.

[6]  Fan Wang,et al.  The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma , 2014, PloS one.

[7]  Neil O. Carragher,et al.  Quantitative phenotypic and pathway profiling guides rational drug combination strategies , 2014, Front. Pharmacol..

[8]  Joon Young Choi,et al.  Synergistic Anti-Cancer Effect of Phenformin and Oxamate , 2014, PloS one.

[9]  S. Mandrekar Dose-finding trial designs for combination therapies in oncology. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Ramanathan,et al.  Network‐Based Approaches in Drug Discovery and Early Development , 2013, Clinical pharmacology and therapeutics.

[11]  Ali Masoudi-Nejad,et al.  Drug-target and disease networks: polypharmacology in the post-genomic era , 2013, In Silico Pharmacology.

[12]  B. Al-Lazikani,et al.  Drugging cancer genomes , 2013, Nature Reviews Drug Discovery.

[13]  Judith A. Blake,et al.  The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse , 2013, Nucleic Acids Res..

[14]  Shang-Yi Huang,et al.  Novel AKT Inhibitor Afuresertib In Combination With Bortezomib and Dexamethasone Demonstrates Favorable Safety Profile and Significant Clinical Activity In Patients With Relapsed/Refractory Multiple Myeloma , 2013 .

[15]  J. Luban,et al.  Overcoming current limitations in humanized mouse research. , 2013, The Journal of infectious diseases.

[16]  Orla Mulhern,et al.  Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice. , 2013, The Journal of infectious diseases.

[17]  Tina Eliassi-Rad,et al.  Which Network Similarity Measure Should You Choose: An Empirical Study , 2013 .

[18]  Jie Li,et al.  Characterization of regulatory features of housekeeping and tissue-specific regulators within tissue regulatory networks , 2013, BMC Systems Biology.

[19]  Mona Singh,et al.  Simple Topological Features Reflect Dynamics and Modularity in Protein Interaction Networks , 2013, PLoS Comput. Biol..

[20]  Albert-László Barabási,et al.  Universality in network dynamics , 2013, Nature Physics.

[21]  Önder Gürcan,et al.  An Emergent Model for Mimicking Human Neuronal Pathways in Silico , 2013, ECAL.

[22]  Tao Xu,et al.  Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways , 2013, PLoS Comput. Biol..

[23]  H. Wen,et al.  Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms , 2013, Pharmaceutical development and technology.

[24]  Hongwei Liang,et al.  The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells , 2013, Molecular Cancer.

[25]  Rong Xu,et al.  Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing , 2013, BMC Bioinformatics.

[26]  Christian Drosten,et al.  Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.

[27]  Mario Albrecht,et al.  NetworkPrioritizer: a versatile tool for network-based prioritization of candidate disease genes or other molecules , 2013, Bioinform..

[28]  Alexander E. Ivliev,et al.  Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach , 2013, PloS one.

[29]  Isidro Cortes-Ciriano,et al.  Experimental validation of in silico target predictions on synergistic protein targets , 2013, Journal of Cheminformatics.

[30]  Riccardo Bellazzi,et al.  Network-based target ranking for polypharmacological therapies , 2013, J. Biomed. Informatics.

[31]  Casey S. Greene,et al.  Functional Knowledge Transfer for High-accuracy Prediction of Under-studied Biological Processes , 2013, PLoS Comput. Biol..

[32]  Walter A. Kosters,et al.  Computing the Eccentricity Distribution of Large Graphs , 2013, Algorithms.

[33]  M. Bogyo,et al.  Target deconvolution techniques in modern phenotypic profiling. , 2013, Current opinion in chemical biology.

[34]  Xiaohui Lin,et al.  A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[35]  A. Guekht,et al.  Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action , 2012, Journal of the Neurological Sciences.

[36]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[37]  Sergio Contrino,et al.  InterMine: a flexible data warehouse system for the integration and analysis of heterogeneous biological data , 2012, Bioinform..

[38]  Danai Koutra,et al.  NetSimile: A Scalable Approach to Size-Independent Network Similarity , 2012, ArXiv.

[39]  Yoshihiro Yamanishi,et al.  Relating drug–protein interaction network with drug side effects , 2012, Bioinform..

[40]  Matthew S. Creamer,et al.  Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling , 2012, BMC Systems Biology.

[41]  I. Jurisica,et al.  Network-based characterization of drug-regulated genes, drug targets, and toxicity. , 2012, Methods.

[42]  Igor Goryanin,et al.  Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 network , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[43]  Erik De Schutter,et al.  A Stochastic Signaling Network Mediates the Probabilistic Induction of Cerebellar Long-Term Depression , 2012, The Journal of Neuroscience.

[44]  Y. Moreau,et al.  Computational tools for prioritizing candidate genes: boosting disease gene discovery , 2012, Nature Reviews Genetics.

[45]  A. Mitra,et al.  Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products , 2012, The AAPS Journal.

[46]  I. Cree,et al.  Targeting EGFR and PI3K pathways in ovarian cancer , 2012, British Journal of Cancer.

[47]  Shaojie Qiao,et al.  Importance Evaluation of Individuals in Online Social Networks Based on Fuzzy AHP Algorithm , 2012 .

[48]  Virginia Vassilevska Williams,et al.  Multiplying matrices faster than coppersmith-winograd , 2012, STOC '12.

[49]  Elhanan Borenstein,et al.  Computational systems biology and in silico modeling of the human microbiome , 2012, Briefings Bioinform..

[50]  S. Arold,et al.  Noise in cellular signaling pathways: causes and effects. , 2012, Trends in biochemical sciences.

[51]  Courtney Corley,et al.  Topological analysis of protein co-abundance networks identifies novel host targets important for HCV infection and pathogenesis , 2012, BMC Systems Biology.

[52]  J. Kotz,et al.  Phenotypic screening, take two , 2012 .

[53]  Jeremy S Logue,et al.  Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. , 2012, Genes & development.

[54]  An Pan,et al.  White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review , 2012, BMJ : British Medical Journal.

[55]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[56]  B. Viollet,et al.  Cellular and molecular mechanisms of metformin: an overview. , 2012, Clinical science.

[57]  A. Shelling,et al.  In Vivo Testing of MicroRNA-Mediated Gene Knockdown in Zebrafish , 2012, Journal of biomedicine & biotechnology.

[58]  Mamoru Ito,et al.  Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.

[59]  Chong-Jing Zhang,et al.  Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes. , 2012, Journal of the American Chemical Society.

[60]  Sourav S. Bhowmick,et al.  PANI: an interactive data-driven tool for target prioritization in signaling networks , 2012, IHI '12.

[61]  David Olmos,et al.  First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Ranadip Pal,et al.  A Kinase Inhibition Map Approach for Tumor Sensitivity Prediction and Combination Therapy Design for Targeted Drugs , 2011, Pacific Symposium on Biocomputing.

[63]  Jimeng Sun,et al.  Centralities in Large Networks: Algorithms and Observations , 2011, SDM.

[64]  R. Bast,et al.  Molecular approaches to personalizing management of ovarian cancer. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[65]  John O'Quigley,et al.  Continual Reassessment Method for Partial Ordering , 2011, Biometrics.

[66]  Nicola J. Mulder,et al.  Generation and Analysis of Large-Scale Data-Driven Mycobacterium tuberculosis Functional Networks for Drug Target Identification , 2011, Adv. Bioinformatics.

[67]  C. Arteaga The phosphatidylinositol-3 kinase/mTOR pathway: new agents , 2011, Breast Cancer Research.

[68]  Gang Feng,et al.  Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..

[69]  T. Mizushima,et al.  Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis , 2011, PloS one.

[70]  T. Spiro,et al.  Pulmonary toxicities of tyrosine kinase inhibitors. , 2011, Clinical advances in hematology & oncology : H&O.

[71]  R. Tallarida,et al.  Quantitative methods for assessing drug synergism. , 2011, Genes & cancer.

[72]  Shao Q Yao,et al.  Proteome profiling reveals potential cellular targets of staurosporine using a clickable cell-permeable probe. , 2011, Chemical communications.

[73]  Andreas Hoppe,et al.  Metannogen: annotation of biological reaction networks , 2011, Bioinform..

[74]  Kuo-Chen Chou,et al.  Docking and molecular dynamics simulations of peroxisome proliferator activated receptors interacting with pan agonist sodelglitazar. , 2011, Protein and peptide letters.

[75]  M. Cloutier,et al.  Dynamic modeling and analysis of cancer cellular network motifs. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[76]  Shou-De Lin,et al.  Cost-Sensitive Multi-Label Learning for Audio Tag Annotation and Retrieval , 2011, IEEE Transactions on Multimedia.

[77]  Santiago Ramón-García,et al.  Synergistic Drug Combinations for Tuberculosis Therapy Identified by a Novel High-Throughput Screen , 2011, Antimicrobial Agents and Chemotherapy.

[78]  Reinhard Schneider,et al.  Using graph theory to analyze biological networks , 2011, BioData Mining.

[79]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[80]  Joel Lexchin,et al.  The cost of drug development: a systematic review. , 2011, Health policy.

[81]  D. Pe’er,et al.  Principles and Strategies for Developing Network Models in Cancer , 2011, Cell.

[82]  T. Spicer,et al.  Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors , 2011, Proceedings of the National Academy of Sciences.

[83]  Bolin Ding,et al.  Fast Set Intersection in Memory , 2011, Proc. VLDB Endow..

[84]  Lokesh P. Tripathi,et al.  TargetMine, an Integrated Data Warehouse for Candidate Gene Prioritisation and Target Discovery , 2011, PloS one.

[85]  Luis G Valerio,et al.  In silico toxicology models and databases as FDA Critical Path Initiative toolkits , 2011, Human Genomics.

[86]  Alan Ashworth,et al.  Searching for synthetic lethality in cancer. , 2011, Current opinion in genetics & development.

[87]  Z. Paroush,et al.  Substrate-dependent control of MAPK phosphorylation in vivo , 2011, Molecular systems biology.

[88]  Giancarlo Troncone,et al.  The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. , 2010, Endocrine-related cancer.

[89]  Fengxi Song,et al.  Feature Selection Using Principal Component Analysis , 2010, 2010 International Conference on System Science, Engineering Design and Manufacturing Informatization.

[90]  Kara Dolinski,et al.  The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..

[91]  Channing J Der,et al.  TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling , 2010, Journal of molecular signaling.

[92]  A. Casadevall,et al.  Reproducible Science , 2010, Infection and Immunity.

[93]  Yiling Lu,et al.  Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. , 2010, Cancer research.

[94]  S. Dulchavsky,et al.  Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells. , 2010, Anticancer research.

[95]  M. Bogyo,et al.  Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes. , 2010, Chemistry & biology.

[96]  Tsviya Olender,et al.  GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.

[97]  David S. Roos,et al.  Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach , 2010, PLoS neglected tropical diseases.

[98]  Ramon Gonzalez,et al.  Metabolic Analysis of Wild-type Escherichia coli and a Pyruvate Dehydrogenase Complex (PDHC)-deficient Derivative Reveals the Role of PDHC in the Fermentative Metabolism of Glucose* , 2010, The Journal of Biological Chemistry.

[99]  Sergei Maslov,et al.  Protein abundances and interactions coevolve to promote functional complexes while suppressing non-specific binding , 2010, 1007.2668.

[100]  Jeffrey R. Wang,et al.  Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer. , 2010, International journal of oncology.

[101]  K. Flaherty,et al.  Safety and efficacy results from the first-in-human study of the oral MEK 1/2 inhibitor GSK1120212. , 2010 .

[102]  R. Turner,et al.  Eigenvector Centrality Mapping for Analyzing Connectivity Patterns in fMRI Data of the Human Brain , 2010, PloS one.

[103]  Jian-Hua Tong,et al.  Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML , 2010, Science.

[104]  Ross S Hall,et al.  Drug target prediction and prioritization: using orthology to predict essentiality in parasite genomes , 2010, BMC Genomics.

[105]  D. Greiner,et al.  Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.

[106]  Benjamin Markman,et al.  Status of PI3K inhibition and biomarker development in cancer therapeutics. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[107]  Benjamin A. Ellingson,et al.  Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database , 2010, J. Chem. Inf. Model..

[108]  Judith B. Zaugg,et al.  Bacterial adaptation through distributed sensing of metabolic fluxes , 2010, Molecular systems biology.

[109]  George Haughn,et al.  Reverse genetics techniques: engineering loss and gain of gene function in plants. , 2010, Briefings in functional genomics.

[110]  J. Engelman,et al.  The PI3K pathway as drug target in human cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[111]  R. Abraham,et al.  Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor. , 2010, Journal of medicinal chemistry.

[112]  Sylvain Meloche,et al.  From basic research to clinical development of MEK1/2 inhibitors for cancer therapy , 2010, Journal of hematology & oncology.

[113]  N. Poulter,et al.  Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis , 2010, Hypertension.

[114]  R. Brereton,et al.  Support vector machines for classification and regression. , 2010, The Analyst.

[115]  Leon Fogelfeld,et al.  Tagatose: from a sweetener to a new diabetic medication? , 2010, Expert opinion on investigational drugs.

[116]  Gary D Bader,et al.  NetPath: a public resource of curated signal transduction pathways , 2010, Genome Biology.

[117]  Laurie G. Hudson,et al.  Targeting the EGF Receptor for Ovarian Cancer Therapy , 2009, Journal of oncology.

[118]  H. Verheul,et al.  Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? , 2009, Angiogenesis.

[119]  J. Post,et al.  ERK Nuclear Translocation Is Dimerization-independent but Controlled by the Rate of Phosphorylation*♦ , 2009, The Journal of Biological Chemistry.

[120]  Uri Keich,et al.  Reliability and efficiency of algorithms for computing the significance of the Mann–Whitney test , 2009, Comput. Stat..

[121]  Zhe Zhang,et al.  Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study , 2009, BMC medicine.

[122]  Patricia Amara,et al.  Structure–function relationships of anaerobic gas-processing metalloenzymes , 2009, Nature.

[123]  Thierry Emonet,et al.  Understanding Modularity in Molecular Networks Requires Dynamics , 2009, Science Signaling.

[124]  Eszter Bohus,et al.  Cluster analysis statistical spectroscopy using nuclear magnetic resonance generated metabolic data sets from perturbed biological systems. , 2009, Analytical chemistry.

[125]  Guohua Wang,et al.  Reconstruct gene regulatory network using slice pattern model , 2009, BMC Genomics.

[126]  V. Grantcharova,et al.  Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis , 2009, Science Signaling.

[127]  John S. Rumsfeld,et al.  Medication Adherence: Its Importance in Cardiovascular Outcomes , 2009, Circulation.

[128]  P. Aloy,et al.  A network medicine approach to human disease , 2009, FEBS letters.

[129]  J. Medina-Franco,et al.  Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1 , 2009, ChemMedChem.

[130]  Steffen Klamt,et al.  Hypergraphs and Cellular Networks , 2009, PLoS Comput. Biol..

[131]  Vasyl Pihur,et al.  RankAggreg, an R package for weighted rank aggregation , 2009, BMC Bioinformatics.

[132]  Yanqing Zhang,et al.  SVMs Modeling for Highly Imbalanced Classification , 2009, IEEE Transactions on Systems, Man, and Cybernetics, Part B (Cybernetics).

[133]  Laura M. Heiser,et al.  Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. , 2009, Cancer research.

[134]  E. Giralt,et al.  Knitting and untying the protein network: Modulation of protein ensembles as a therapeutic strategy , 2008, Protein science : a publication of the Protein Society.

[135]  M. Fukumoto,et al.  KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer , 2008, British Journal of Cancer.

[136]  Foster Provost,et al.  Machine Learning from Imbalanced Data Sets 101 , 2008 .

[137]  L. Lai,et al.  Finding multiple target optimal intervention in disease-related molecular network , 2008, Molecular systems biology.

[138]  O. Kuchaiev,et al.  Topological network alignment uncovers biological function and phylogeny , 2008, Journal of The Royal Society Interface.

[139]  Gongping Yang,et al.  On the Class Imbalance Problem , 2008, 2008 Fourth International Conference on Natural Computation.

[140]  Allen D. Roses,et al.  Pharmacogenetics in drug discovery and development: a translational perspective , 2008, Nature Reviews Drug Discovery.

[141]  Bonnie Berger,et al.  Global alignment of multiple protein interaction networks with application to functional orthology detection , 2008, Proceedings of the National Academy of Sciences.

[142]  Kwang-Hyun Cho,et al.  Coherent coupling of feedback loops: a design principle of cell signaling networks , 2008, Bioinform..

[143]  Jian Huang,et al.  Penalized feature selection and classification in bioinformatics , 2008, Briefings Bioinform..

[144]  Aidong Zhang,et al.  Bridging centrality: graph mining from element level to group level , 2008, KDD.

[145]  Luay Nakhleh,et al.  Rapidly exploring structural and dynamic properties of signaling networks using PathwayOracle , 2008, BMC Systems Biology.

[146]  Zhike Zi,et al.  SBML-SAT: a systems biology markup language (SBML) based sensitivity analysis tool , 2008, BMC Bioinformatics.

[147]  Andreas Christmann,et al.  Support vector machines , 2008, Data Mining and Knowledge Discovery Handbook.

[148]  Yan Gao,et al.  Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Epithelial Ovarian Cancer , 2008, Molecular Cancer Research.

[149]  S. P. Ivy,et al.  Cediranib (AZD2171) is an active agent in recurrent epithelial ovarian cancer , 2008 .

[150]  F. Schreiber,et al.  Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks , 2008, Gene regulation and systems biology.

[151]  Øyvind Drivenes,et al.  Treatment with small interfering RNA affects the microRNA pathway and causes unspecific defects in zebrafish embryos , 2008, The FEBS journal.

[152]  Dario Rossi,et al.  Support vector regression for link load prediction , 2008, 2008 4th International Telecommunication Networking Workshop on QoS in Multiservice IP Networks.

[153]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[154]  R. Sun,et al.  Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.

[155]  Michael Hucka,et al.  LibSBML: an API Library for SBML , 2008, Bioinform..

[156]  Jacob D. Feala,et al.  Search Algorithms as a Framework for the Optimization of Drug Combinations , 2008, PLoS Comput. Biol..

[157]  Ron Bose,et al.  Mechanism of activation and inhibition of the HER4/ErbB4 kinase. , 2008, Structure.

[158]  N. Nachar The Mann-Whitney U: A Test for Assessing Whether Two Independent Samples Come from the Same Distribution , 2008 .

[159]  Tijana Milenkoviæ,et al.  Uncovering Biological Network Function via Graphlet Degree Signatures , 2008, Cancer informatics.

[160]  N. Barkai,et al.  Variability and robustness in biomolecular systems. , 2007, Molecular cell.

[161]  Yang Wang,et al.  Cost-sensitive boosting for classification of imbalanced data , 2007, Pattern Recognit..

[162]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[163]  Jean-Marc Schwartz,et al.  A global view of drug-therapy interactions , 2007, BMC pharmacology.

[164]  Xiaowei Zhuang,et al.  Kinetic analysis of sequential multistep reactions. , 2007, The journal of physical chemistry. B.

[165]  Jiguo Cao,et al.  Parameter estimation for differential equations: a generalized smoothing approach , 2007 .

[166]  Kristiina Vuori,et al.  The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures , 2007, Molecular Cancer Therapeutics.

[167]  Man Lung Yiu,et al.  Efficient top-k aggregation of ranked inputs , 2007, TODS.

[168]  G. King,et al.  The role of protein kinase C activation in diabetic nephropathy. , 2007, Kidney international. Supplement.

[169]  M. Blagosklonny,et al.  Antagonistic drug combinations that select against drug resistance: From bacteria to cancer , 2007, Cancer biology & therapy.

[170]  Ulf Leser,et al.  Fast and practical indexing and querying of very large graphs , 2007, SIGMOD '07.

[171]  Patrick L. Harrington,et al.  Selective Control of the Apoptosis Signaling Network in Heterogeneous Cell Populations , 2007, PloS one.

[172]  John M. Hancock,et al.  A kinetic core model of the glucose-stimulated insulin secretion network of pancreatic β cells , 2007, Mammalian Genome.

[173]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[174]  Vivienne Marsh,et al.  Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor , 2007, Clinical Cancer Research.

[175]  David S Mendelson,et al.  Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[176]  Quan-guang Zhang,et al.  Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury , 2007, FEBS letters.

[177]  Ravi Iyengar,et al.  Compartment-specific feedback loop and regulated trafficking can result in sustained activation of Ras at the Golgi. , 2007, Biophysical journal.

[178]  Li Wang,et al.  CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data , 2007, Bioinform..

[179]  G. Fagiolo Clustering in complex directed networks. , 2006, Physical review. E, Statistical, nonlinear, and soft matter physics.

[180]  H. Herzel,et al.  UniHI: an entry gate to the human protein interactome , 2006, Nucleic Acids Res..

[181]  Mudita Singhal,et al.  Simulation of Biochemical Networks using Copasi - A Complex Pathway Simulator , 2006, Proceedings of the 2006 Winter Simulation Conference.

[182]  N. Riel Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments , 2006, Briefings Bioinform..

[183]  D. Lauffenburger,et al.  Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.

[184]  G. Wray,et al.  Endo16 is required for gastrulation in the sea urchin Lytechinus variegatus , 2006, Development, growth & differentiation.

[185]  R. Shoemaker The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[186]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[187]  R. Copeland,et al.  Drug–target residence time and its implications for lead optimization , 2006, Nature Reviews Drug Discovery.

[188]  S. Wilhelm,et al.  Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. , 2006, Seminars in oncology.

[189]  Victor S. Sheng,et al.  Thresholding for Making Classifiers Cost-sensitive , 2006, AAAI.

[190]  Vincent Conitzer,et al.  Improved Bounds for Computing Kemeny Rankings , 2006, AAAI.

[191]  Chun-Nan Hsu,et al.  FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization , 2006, Nucleic Acids Res..

[192]  Jesse Davis,et al.  The relationship between Precision-Recall and ROC curves , 2006, ICML.

[193]  C. Johnston,et al.  Vinegar: medicinal uses and antiglycemic effect. , 2006, MedGenMed : Medscape general medicine.

[194]  Jianzhi Zhang,et al.  Why Do Hubs Tend to Be Essential in Protein Networks? , 2006, PLoS genetics.

[195]  Samiul Hasan,et al.  Prioritizing Genomic Drug Targets in Pathogens: Application to Mycobacterium tuberculosis , 2006, PLoS Comput. Biol..

[196]  Julie Morris,et al.  Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo , 2006, Breast Cancer Research.

[197]  Philip S. Yu,et al.  Dual Labeling: Answering Graph Reachability Queries in Constant Time , 2006, 22nd International Conference on Data Engineering (ICDE'06).

[198]  Chris F. Taylor,et al.  The MGED Ontology: a resource for semantics-based description of microarray experiments , 2006, Bioinform..

[199]  D-M Hu,et al.  Time-dependent sensitivity analysis of biological networks: coupled MAPK and PI3K signal transduction pathways. , 2006, The journal of physical chemistry. A.

[200]  Jacky L. Snoep,et al.  BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems , 2005, Nucleic Acids Res..

[201]  Ivor W. Tsang,et al.  Core Vector Machines: Fast SVM Training on Very Large Data Sets , 2005, J. Mach. Learn. Res..

[202]  R. Albert Scale-free networks in cell biology , 2005, Journal of Cell Science.

[203]  Jaime Prat,et al.  Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[204]  Li Chen,et al.  Stack-based Algorithms for Pattern Matching on DAGs , 2005, VLDB.

[205]  B. Brandt,et al.  The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches. , 2005, Histology and histopathology.

[206]  Alan J Wolfe,et al.  Glucose metabolism at high density growth of E. coli B and E. coli K: differences in metabolic pathways are responsible for efficient glucose utilization in E. coli B as determined by microarrays and Northern blot analyses. , 2005, Biotechnology and bioengineering.

[207]  D. Verbanac,et al.  Combined in silico and in vitro approach to drug screening , 2005 .

[208]  Tao Jiang,et al.  MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[209]  Jenny Bangham,et al.  Therapeutics: Cetuximab constricts conformational contortionist , 2005, Nature Reviews Cancer.

[210]  U. Sauer,et al.  Impact of Global Transcriptional Regulation by ArcA, ArcB, Cra, Crp, Cya, Fnr, and Mlc on Glucose Catabolism in Escherichia coli , 2005, Journal of bacteriology.

[211]  P. Postma,et al.  Reducing the glucose uptake rate in Escherichia coli affects growth rate but not protein production. , 2005, Biotechnology and bioengineering.

[212]  Zixiang Xiong,et al.  Optimal number of features as a function of sample size for various classification rules , 2005, Bioinform..

[213]  R P Araujo,et al.  A mathematical model of combination therapy using the EGFR signaling network. , 2005, Bio Systems.

[214]  L. Solnica-Krezel Conserved Patterns of Cell Movements during Vertebrate Gastrulation , 2005, Current Biology.

[215]  Tian-Li Wang,et al.  Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. , 2005, Cancer research.

[216]  I. Y. Kim,et al.  Adaptive weighted-sum method for bi-objective optimization: Pareto front generation , 2005 .

[217]  F. Sams-Dodd Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[218]  Péter Csermely,et al.  The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.

[219]  J. Au,et al.  Evaluation of Combination Chemotherapy , 2004, Clinical Cancer Research.

[220]  Holger Sondermann,et al.  Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless , 2004, Cell.

[221]  Hao Chen,et al.  Content-rich biological network constructed by mining PubMed abstracts , 2004, BMC Bioinformatics.

[222]  Rosemary Steinmetz,et al.  Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. , 2004, Molecular endocrinology.

[223]  Stephen Kwek,et al.  Applying Support Vector Machines to Imbalanced Datasets , 2004, ECML.

[224]  Bernhard Schölkopf,et al.  A tutorial on support vector regression , 2004, Stat. Comput..

[225]  Kai Wang,et al.  A non‐parametric approach to the design and analysis of two‐dimensional dose‐finding trials , 2004, Statistics in medicine.

[226]  K. Shimizu,et al.  Metabolic regulation analysis of icd-gene knockout Escherichia coli based on 2D electrophoresis with MALDI-TOF mass spectrometry and enzyme activity measurements , 2004, Applied Microbiology and Biotechnology.

[227]  Michael Koutsilieris,et al.  The Akt pathway: molecular targets for anti-cancer drug development. , 2004, Current cancer drug targets.

[228]  Joseph Shiloach,et al.  Transcription levels of key metabolic genes are the cause for different glucose utilization pathways in E. coli B (BL21) and E. coli K (JM109). , 2004, Journal of biotechnology.

[229]  T. McShane,et al.  Development and Use of Biomarkers in Oncology Drug Development , 2004, Toxicologic pathology.

[230]  John Langford,et al.  Cost-sensitive learning by cost-proportionate example weighting , 2003, Third IEEE International Conference on Data Mining.

[231]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[232]  Malcolm S. Mitchell,et al.  Combinations of anticancer drugs and immunotherapy , 2003, Cancer Immunology, Immunotherapy.

[233]  Huan Liu,et al.  Feature Selection for High-Dimensional Data: A Fast Correlation-Based Filter Solution , 2003, ICML.

[234]  A. Brodie Aromatase inhibitor development and hormone therapy: a perspective. , 2003, Seminars in oncology.

[235]  S. Kimura,et al.  A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. , 2003, The Biochemical journal.

[236]  Jun'ichi Tsujii,et al.  GENIA corpus - a semantically annotated corpus for bio-textmining , 2003, ISMB.

[237]  Marketa Zvelebil,et al.  Phosphoinositide 3-kinase signalling--which way to target? , 2003, Trends in pharmacological sciences.

[238]  J. Lehár,et al.  Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[239]  J. Grandis,et al.  Activation of Stat3 by cell confluence reveals negative regulation of Stat3 by cdk2 , 2003, Oncogene.

[240]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[241]  Annabel E. Todd,et al.  Target Selection and Determination of Function in Structural Genomics , 2003, IUBMB life.

[242]  G. Carpenter,et al.  ErbB-4: mechanism of action and biology. , 2003, Experimental cell research.

[243]  N. Normanno,et al.  Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. , 2003, Endocrine-related cancer.

[244]  C. Dominguez,et al.  HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.

[245]  Joseph Schlessinger,et al.  Ligand-Induced, Receptor-Mediated Dimerization and Activation of EGF Receptor , 2002, Cell.

[246]  Hyeran Byun,et al.  Applications of Support Vector Machines for Pattern Recognition: A Survey , 2002, SVM.

[247]  Jean Girard,et al.  Effects of benfluorex on fatty acid and glucose metabolism in isolated rat hepatocytes: from metabolic fluxes to gene expression. , 2002, Diabetes.

[248]  B. Kreider,et al.  Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. , 2002, Chemistry & biology.

[249]  Sayan Mukherjee,et al.  Choosing Multiple Parameters for Support Vector Machines , 2002, Machine Learning.

[250]  Liang Qiao,et al.  Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. , 2002, Frontiers in bioscience : a journal and virtual library.

[251]  M E J Newman,et al.  Community structure in social and biological networks , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[252]  Kathy Chen,et al.  Network dynamics and cell physiology , 2001, Nature Reviews Molecular Cell Biology.

[253]  T Li,et al.  Performance of batch membrane reactor: Glycerol-3-phosphate synthesis coupled with adenosine triphosphate regeneration. , 2001, Biotechnology and bioengineering.

[254]  A. Adjei,et al.  Blocking oncogenic Ras signaling for cancer therapy. , 2001, Journal of the National Cancer Institute.

[255]  G Asselin,et al.  Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. , 2001, American journal of physiology. Endocrinology and metabolism.

[256]  J. Thomas,et al.  An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles. , 2001, Genome research.

[257]  Phillip Bonacich,et al.  Eigenvector-like measures of centrality for asymmetric relations , 2001, Soc. Networks.

[258]  George M. Church,et al.  Aligning gene expression time series with time warping algorithms , 2001, Bioinform..

[259]  U. Brandes A faster algorithm for betweenness centrality , 2001 .

[260]  J. Suykens Nonlinear modelling and support vector machines , 2001, IMTC 2001. Proceedings of the 18th IEEE Instrumentation and Measurement Technology Conference. Rediscovering Measurement in the Age of Informatics (Cat. No.01CH 37188).

[261]  Moni Naor,et al.  Rank aggregation methods for the Web , 2001, WWW '01.

[262]  I. Sobola,et al.  Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates , 2001 .

[263]  S. Ellner,et al.  Crossing the hopf bifurcation in a live predator-prey system. , 2000, Science.

[264]  J. Maxa,et al.  Drug Interactions Due to Cytochrome P450 , 2000, Proceedings.

[265]  S. Ekker,et al.  Effective targeted gene ‘knockdown’ in zebrafish , 2000, Nature Genetics.

[266]  Nello Cristianini,et al.  Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..

[267]  Rainer Schrader,et al.  A Note on the Finite Time Behavior of Simulated Annealing , 2000, Math. Oper. Res..

[268]  Monilola A. Olayioye,et al.  The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.

[269]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[270]  J. Nemunaitis,et al.  A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[271]  Chris N. Potts,et al.  Constraint satisfaction problems: Algorithms and applications , 1999, Eur. J. Oper. Res..

[272]  Jae-Gu Pan,et al.  Acetate Metabolism in a pta Mutant ofEscherichia coli W3110: Importance of Maintaining Acetyl Coenzyme A Flux for Growth and Survival , 1999, Journal of bacteriology.

[273]  Carmen Bambach,et al.  Drawing and Painting in the Italian Renaissance Workshop: Theory and Practice, 1300–1600 , 1999 .

[274]  Pedro M. Domingos MetaCost: a general method for making classifiers cost-sensitive , 1999, KDD '99.

[275]  Si Wu,et al.  Improving support vector machine classifiers by modifying kernel functions , 1999, Neural Networks.

[276]  B. Hemmings,et al.  Regulation of protein kinase cascades by protein phosphatase 2A. , 1999, Trends in biochemical sciences.

[277]  U. Bhalla,et al.  Emergent properties of networks of biological signaling pathways. , 1999, Science.

[278]  Advances in Kernel Methods , 1998 .

[279]  J L Sussman,et al.  Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. , 1998, Acta crystallographica. Section D, Biological crystallography.

[280]  Kai Ming Ting,et al.  Inducing Cost-Sensitive Trees via Instance Weighting , 1998, PKDD.

[281]  R. C. Williamson,et al.  Support vector regression with automatic accuracy control. , 1998 .

[282]  Duncan J. Watts,et al.  Collective dynamics of ‘small-world’ networks , 1998, Nature.

[283]  Christopher J. C. Burges,et al.  A Tutorial on Support Vector Machines for Pattern Recognition , 1998, Data Mining and Knowledge Discovery.

[284]  Massimiliano Pontil,et al.  Support Vector Machines for 3D Object Recognition , 1998, IEEE Trans. Pattern Anal. Mach. Intell..

[285]  J. Shiloach,et al.  Proposed mechanism of acetate accumulation in two recombinant Escherichia coli strains during high density fermentation. , 1998, Biotechnology and bioengineering.

[286]  Nir Friedman,et al.  Bayesian Network Classifiers , 1997, Machine Learning.

[287]  W. R. Farmer,et al.  Reduction of aerobic acetate production by Escherichia coli , 1997, Applied and environmental microbiology.

[288]  Markus Schulze,et al.  Morphologie, Syntax und Semantik im Rahmen der linksassoziativen Grammatik , 1997, GLDV-Jahrestagung.

[289]  John Bell,et al.  A review of methods for the assessment of prediction errors in conservation presence/absence models , 1997, Environmental Conservation.

[290]  Lothar Thiele,et al.  A Comparison of Selection Schemes Used in Evolutionary Algorithms , 1996, Evolutionary Computation.

[291]  Luís Torgo,et al.  Regression by Classification , 1996, SBIA.

[292]  D. Saari,et al.  The Copeland method , 1996 .

[293]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[294]  Bart Selman,et al.  Systematic Versus Stochastic Constraint Satisfaction , 1995, IJCAI.

[295]  S. Shapiro,et al.  Mathematics without Numbers , 1993 .

[296]  G. Castañeda-Hernández,et al.  Analgesic effects of combinations containing opioid drugs with either aspirin or acetaminophen in the rat , 1993 .

[297]  David A. Landgrebe,et al.  A survey of decision tree classifier methodology , 1991, IEEE Trans. Syst. Man Cybern..

[298]  Lawrence A Leiter,et al.  Cellular Mechanism of Action of Metformin , 1990, Diabetes Care.

[299]  Joost Engelfriet,et al.  A Comparison of Boundary Graph Grammars and Context-Free Hypergraph Grammars , 1990, Inf. Comput..

[300]  L. Darrell Whitley,et al.  The GENITOR Algorithm and Selection Pressure: Why Rank-Based Allocation of Reproductive Trials is Best , 1989, ICGA.

[301]  Carlo Gaibisso,et al.  A Partially Persistent Data Structure for the Set-Union Problem with Backtracking , 1988, IMYCS.

[302]  Kishor S. Trivedi,et al.  Numerical transient analysis of markov models , 1988, Comput. Oper. Res..

[303]  J. Azuma,et al.  Mechanism of direct cardiostimulating actions of hydralazine. , 1987, European journal of pharmacology.

[304]  P. Waage,et al.  Studies concerning affinity , 1986 .

[305]  Robert E. Tarjan,et al.  Fibonacci heaps and their uses in improved network optimization algorithms , 1984, JACM.

[306]  W. L. Chiou,et al.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve , 1978, Journal of Pharmacokinetics and Biopharmaceutics.

[307]  Teofilo F. Gonzalez,et al.  An Efficient Algorithm for the Kolmogorov-Smirnov and Lilliefors Tests , 1977, TOMS.

[308]  M. Stephens EDF Statistics for Goodness of Fit and Some Comparisons , 1974 .

[309]  Robert E. Tarjan,et al.  Depth-First Search and Linear Graph Algorithms , 1972, SIAM J. Comput..

[310]  Peter C. Fishburn,et al.  Letter to the Editor - Additive Utilities with Incomplete Product Sets: Application to Priorities and Assignments , 1967, Oper. Res..

[311]  Edsger W. Dijkstra,et al.  A note on two problems in connexion with graphs , 1959, Numerische Mathematik.

[312]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[313]  P. Jaccard THE DISTRIBUTION OF THE FLORA IN THE ALPINE ZONE.1 , 1912 .

[314]  Natasa Przulj Biological. , 1895, The journals of gerontology. Series A, Biological sciences and medical sciences.

[315]  S. Ratsimamanga,et al.  SODIUM OXAMATE FOR THE TREATMENT OF DABETC CONDITIONS , 2017 .

[316]  Anna M. Ritz,et al.  Signaling hypergraphs. , 2014, Trends in biotechnology.

[317]  Américo Pereira,et al.  Review of feature selection techniques in bioinformatics , 2012 .

[318]  Ritika,et al.  Formulation Tactics for the Delivery of Poorly Soluble Drugs , 2012 .

[319]  R. Tiwari,et al.  Drug delivery systems: An updated review , 2012, International journal of pharmaceutical investigation.

[320]  M. Kemal Sönmez,et al.  Computing graphlet signatures of network nodes and motifs in Cytoscape with GraphletCounter , 2012, Bioinform..

[321]  R. N. Mishra,et al.  Jiao Gu Lan (Gynostemma pentaphyllum): The Chinese Rasayan- Current Research Scenario , 2011 .

[322]  M. Erion,et al.  Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes. , 2011, Handbook of experimental pharmacology.

[323]  Xiang-Sun Zhang,et al.  Drug Target Identification Based on Flux Balance Analysis of Metabolic Networks , 2010 .

[324]  S. Giordano,et al.  ReviewMolecular mechanisms of acquired resistance to tyrosine kinase targeted therapy , 2010 .

[325]  Mona Singh,et al.  Toward the dynamic interactome: it's about time , 2010, Briefings Bioinform..

[326]  Edda Klipp,et al.  Monte Carlo analysis of an ODE Model of the Sea Urchin Endomesoderm Network Supplementary Table 1: Differential Equations , 2009 .

[327]  Chih-Jen Lin,et al.  A Practical Guide to Support Vector Classication , 2008 .

[328]  Tom Fawcett,et al.  ROC Graphs: Notes and Practical Considerations for Researchers , 2007 .

[329]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[330]  Johannes Grotendorst,et al.  Classification of Highly Unbalanced CYP450 Data of Drugs Using Cost Sensitive Machine Learning Techniques , 2007, J. Chem. Inf. Model..

[331]  T. Maiwald,et al.  An error model for protein quantification , 2007, Bioinform..

[332]  R. Thadhani,et al.  Formal trials versus observational studies , 2006 .

[333]  Lorin Roskos,et al.  From XenoMouse® Technology to Panitumumab (ABX-EGF) , 2005 .

[334]  Padhraic Smyth,et al.  Analysis and Visualization of Network Data using JUNG , 2005 .

[335]  Seth Love,et al.  Apoptotic pathways as targets for novel therapies in cancer and other diseases , 2005 .

[336]  Pablo A. Iglesias,et al.  Dynamic Properties of Network Motifs Contribute to Biological Network , 2005 .

[337]  Stan Salvador,et al.  FastDTW: Toward Accurate Dynamic Time Warping in Linear Time and Space , 2004 .

[338]  Boleslaw K. Szymanski,et al.  Taming the Curse of Dimensionality in Kernels and Novelty Detection , 2004, WSC.

[339]  Sheldon Howard Jacobson,et al.  The Theory and Practice of Simulated Annealing , 2003, Handbook of Metaheuristics.

[340]  Mark A. Hall,et al.  Correlation-based Feature Selection for Machine Learning , 2003 .

[341]  Tomasz Winiarski,et al.  Feature Selection Based on Information Theory Filters , 2003 .

[342]  Yanli Wang,et al.  MMDB: Entrez's 3D-structure database , 2003, Nucleic Acids Res..

[343]  B. Druker,et al.  STI571: a paradigm of new agents for cancer therapeutics. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[344]  A. Bhuyan,et al.  Resting membrane potential as a marker of apoptosis: studies on Xenopus oocytes microinjected with cytochrome c , 2001, Cell Death and Differentiation.

[345]  X. F. Zhang,et al.  Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. , 2001, Recent progress in hormone research.

[346]  D. Lauffenburger,et al.  A Computational Study of Feedback Effects on Signal Dynamics in a Mitogen‐Activated Protein Kinase (MAPK) Pathway Model , 2001, Biotechnology progress.

[347]  Eamonn J. Keogh,et al.  Derivative Dynamic Time Warping , 2001, SDM.

[348]  Joshua Alspector,et al.  SVM-based Filtering of E-mail Spam with Content-specic Misclassication Costs , 2001 .

[349]  Samy Bengio,et al.  SVMTorch: Support Vector Machines for Large-Scale Regression Problems , 2001, J. Mach. Learn. Res..

[350]  Klaus Obermayer,et al.  Support vector learning for ordinal regression , 1999 .

[351]  N. Emanuele,et al.  Consequences of Alcohol Use in Diabetics , 1998, Alcohol health and research world.

[352]  M. Debono,et al.  Antibiotics that inhibit fungal cell wall development. , 1994, Annual review of microbiology.

[353]  S. Wasserman,et al.  Social Network Analysis: Methods and Applications , 1994 .

[354]  William L. Goffe,et al.  Global Optimization of Statistical Functions with Simulated Annealing , 1994 .

[355]  K. Reinhardt Sorting In-Place with a Worst Case Complexity of n log n − 1 . 3 n + O ( log n ) Comparisons and ε n log n + O ( 1 ) Transports ∗ , 1992 .

[356]  Stanley Lemeshow,et al.  Applied Logistic Regression, Second Edition , 1989 .

[357]  Lorenz T. Biegler,et al.  Nonlinear parameter estimation: A case study comparison , 1986 .

[358]  H. Bock,et al.  Recent Advances in Parameteridentification Techniques for O.D.E. , 1983 .

[359]  L. Freeman Centrality in social networks conceptual clarification , 1978 .

[360]  R. Graham,et al.  Spearman's Footrule as a Measure of Disarray , 1977 .

[361]  V. Vapnik Pattern recognition using generalized portrait method , 1963 .

[362]  Thomas Marill,et al.  On the effectiveness of receptors in recognition systems , 1963, IEEE Trans. Inf. Theory.

[363]  A. A. Lumsdaine,et al.  The American soldier: Combat and its aftermath. (Studies in social psychology in World War II), Vol. 2 , 1949 .

[364]  P.-C.-F. Daunou,et al.  Mémoire sur les élections au scrutin , 1803 .

[365]  Torsten Schaub,et al.  Under Consideration for Publication in Theory and Practice of Logic Programming Minimal Intervention Strategies in Logical Signaling Networks with Asp , 2022 .